These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2588196)

  • 1. Effect of lipanthyl in hyperlipoproteinaemic diabetic patients.
    Hajós P; Tornyossi M
    Ther Hung; 1989; 37(3):138-43. PubMed ID: 2588196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of fenofibrate on the lipid level in diabetic patients].
    Häring HU; Schleicher E; Renner R; Mehnert H
    MMW Munch Med Wochenschr; 1983 Sep; 125(35):751-3. PubMed ID: 6415427
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hyperlipoproteinemia with lipanthyl].
    Kalinová M; Zadák Z; Sobotka L
    Cas Lek Cesk; 1983 Feb; 122(7):205-8. PubMed ID: 6831503
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hyperlipoproteinemia in patients with diabetes mellitus].
    Dammann HG; Dreyer M; Wernecke J; Lankers H; Müller P; Simon B
    Fortschr Med; 1990 May; 108(15):305-8. PubMed ID: 2204598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etolip and Lipanthyl in the treatment of hyperlipoproteinemia].
    Ceska R; Sobra J; Procházková R; Kvasilová M
    Vnitr Lek; 1990 Apr; 36(4):363-7. PubMed ID: 2356612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of fenofibrate in various types of hyperlipoproteinemias].
    Sucić M
    Lijec Vjesn; 1989 Mar; 111(3):93-7. PubMed ID: 2747411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Procetofen in the treatment of hyperlipoproteinaemias (author's transl)].
    Micheli H; Pometta D
    Schweiz Rundsch Med Prax; 1980 Jan; 69(2):42-6. PubMed ID: 7367386
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
    Cucuianu M; Fekete T; Marcusiu C; Mösler R; Duţu A
    Med Interne; 1984; 22(3):171-7. PubMed ID: 6494764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of lipanthyl on parameters of lipid metabolism in patients with primary hyperlipoproteinemia].
    Sznajd J; Magdoń M; Idzior B; Konarska R; Malczewska M; Czarnecka H
    Przegl Lek; 1984; 41(2):217-21. PubMed ID: 6377392
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
    Kasalová Z; Prázný M; Skrha J
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
    Lapotnikov VA; Moiseev SI
    Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative research on etofibrate retard and fenofibrate in hyperlipoproteinemia].
    Schwartzkopff W; Schilling A
    Med Welt; 1980 Dec; 31(50):1845-50. PubMed ID: 7464535
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of antiaggregants on the course of diabetic microangiopathy].
    Bokarev IN; Velikov VK; Zelenchuk NM; Shubina OI; Saltykov BB; Frolova AI; Polunin GS; Pirogova EP; Nikol'skaia VV; Davydova NG
    Ter Arkh; 1993; 65(3):78-81. PubMed ID: 8059393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension].
    Chazova IE; Mychka VB; Duishvili DE
    Ter Arkh; 2004; 76(8):28-32. PubMed ID: 15471392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence and onset of arterial hypertension and diabetic retinopathy in a population of subjects with diabetes mellitus].
    Repeti M; Urbani A; Barbaro D; Bassano G; Bernini F; Boldrin M; Crestini AM; Lombardo M; Marino O
    Clin Ter; 1994 Jun; 144(6):511-5. PubMed ID: 8001335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasmapheresis in the treatment of critical stages of ischemia in diabetic angiopathy of the lower extremities].
    Georgadze AK; Sokolov SS; Gvozdev NA; Postnikov AA; Sharandak AP
    Vestn Khir Im I I Grek; 1989 Mar; 142(3):20-4. PubMed ID: 2749988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
    Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Total and lipid-bound sialic acids in the blood in primary and secondary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Lupanov VP; Liakishev AA; Titov VN
    Ter Arkh; 1997; 69(1):23-5. PubMed ID: 9163043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the effects of fenofibrate administered in doses of 3 x 100mg and 1 x 250mg per day in patients with type IIA, IIB and IV hyperlipoproteinemias].
    Reiner Z; Salzer B; Kes P
    Acta Med Iugosl; 1988; 42(5):353-62. PubMed ID: 3245481
    [No Abstract]   [Full Text] [Related]  

  • 20. Fenofibrate and cardiovascular risk: a synopsis and commentary on (FIELD).
    Bailey CJ
    Diabet Med; 2006 Feb; 23(2):109-12. PubMed ID: 16433706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.